Regina Stoltz
Overview
Explore the profile of Regina Stoltz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
227
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Qin K, Honjo K, Sherrill-Mix S, Liu W, Stoltz R, Oman A, et al.
medRxiv
. 2023 Jan;
PMID: 36597532
Chronic lymphocytic leukemia (CLL) patients have lower seroconversion rates and antibody titers following SARS-CoV-2 vaccination, but the reasons for this diminished response are poorly understood. Here, we studied humoral and...
2.
Boppana S, Qin K, Files J, Russell R, Stoltz R, Bibollet-Ruche F, et al.
PLoS Pathog
. 2021 Jul;
17(7):e1009761.
PMID: 34270631
T-cell immunity is likely to play a role in protection against SARS-CoV-2 by helping generate neutralizing antibodies. We longitudinally studied CD4 T-cell responses to the M, N, and S structural...
3.
Liu W, Russell R, Bibollet-Ruche F, Skelly A, Sherrill-Mix S, Freeman D, et al.
Emerg Infect Dis
. 2021 Jul;
27(9):2454-2458.
PMID: 34193339
Not all persons recovering from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection develop SARS-CoV-2-specific antibodies. We show that nonseroconversion is associated with younger age and higher reverse transcription PCR...
4.
Patel A, Reuschel E, Xu Z, Zaidi F, Kim K, Scott D, et al.
JCI Insight
. 2021 Apr;
6(10).
PMID: 33886507
Emerging coronaviruses from zoonotic reservoirs, including severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV), and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), have been associated with...
5.
Honjo K, Russell R, Li R, Liu W, Stoltz R, Tabengwa E, et al.
Cell Rep Med
. 2021 Feb;
2(1):100164.
PMID: 33521696
Convalescent plasma (CP) is widely used to treat COVID-19, but without formal evidence of efficacy. Here, we report the beneficial effects of CP in a severely ill COVID-19 patient with...
6.
Boppana S, Qin K, Files J, Russell R, Stoltz R, Bibollet-Ruche F, et al.
medRxiv
. 2020 Oct;
PMID: 33052359
T-cell immunity is likely to play a role in protection against SARS-CoV-2 by helping generate neutralizing antibodies. We longitudinally studied CD4 T-cell responses to the M, N, and S structural...
7.
Duperret E, Perales-Puchalt A, Stoltz R, G H H, Mandloi N, Barlow J, et al.
Cancer Immunol Res
. 2019 Jan;
7(2):174-182.
PMID: 30679156
T-cell recognition of cancer neoantigens is important for effective immune-checkpoint blockade therapy, and an increasing interest exists in developing personalized tumor neoantigen vaccines. Previous studies utilizing RNA and long-peptide neoantigen...
8.
Synthetic DNA-Encoded Monoclonal Antibody Delivery of Anti-CTLA-4 Antibodies Induces Tumor Shrinkage
Duperret E, Trautz A, Stoltz R, Patel A, Wise M, Perales-Puchalt A, et al.
Cancer Res
. 2018 Oct;
78(22):6363-6370.
PMID: 30287678
Antibody-based immune therapies targeting the T-cell checkpoint molecules CTLA-4 and PD-1 have affected cancer therapy. However, this immune therapy requires complex manufacturing and frequent dosing, limiting the global use of...
9.
Duperret E, Liu S, Paik M, Trautz A, Stoltz R, Liu X, et al.
Clin Cancer Res
. 2018 Sep;
24(23):6015-6027.
PMID: 30262507
Purpose: Cancer/testis antigens have emerged as attractive targets for cancer immunotherapy. Clinical studies have targeted MAGE-A3, a prototype antigen that is a member of the MAGE-A family of antigens, in...
10.
Hahn J, Lengerich A, Byrd R, Stoltz R, Hench J, Byrd S, et al.
Creat Nurs
. 2018 Sep;
22(1):45-50.
PMID: 30188305
Babies born to women who have used opioids during pregnancy frequently develop withdrawal symptoms following birth. Although a consistently used protocol is not available to treat these infants, interventions commonly...